Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine vs Nalbuphine with Sufentanil for Postoperative Analgesia in Oral Cancer Surgery
NCT07401641Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dezocine in postoperative pain (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Visual Analogue Scale for Pain Intensity at 48 hours. Started Jun 2025; status: recruiting.
02
Drugs
dezocine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07401641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401641.